Latest News

The Kavli Institute for Neuroscience is pleased to announce the recipients of the 2025 Kavli Postdoctoral Fellowship.

A method developed by Yale scientists helps reveal how antibacterial agents interact with their host cells—a process that could boost a host of applications that benefit society. 

Kristen J. Brennand, PhD, Elizabeth Mears and House Jameson Professor of Psychiatry, has been accepted as a Fellow in the 2025-2026 Hedwig van Ameringen Executive Leadership in Academic Medicine® (ELAM) Program.

The American Association for the Advancement of Science has elected eight Yale faculty members as part of its latest class of fellows.

A new study from scientists at Yale School of Medicine has identified N-acetyltransferase 10 (NAT10), an enzyme highly expressed in brain metastasis, as a driver of brain metastasis. NAT10 primarily functions by adding acetyl groups to RNA molecules, regulating their function, stability or translation.

Yale scientists have developed a CRISPR technology that can assess genetic interactions on a host of immunological responses to multiple diseases, including cancer.

A small number of people report chronic symptoms after receiving COVID-19 shots. A new study provides clues for further research.

Yale researchers have uncovered a new role for mRNA — being part of the “feet” that allow cells to move around the body.

A team of synthetic biologists have re-written the genetic code of an organism using a novel cellular platform for producing new classes of synthetic proteins.